Answers are grounded in this paper and cite their sources.
Highlights the essential regulatory roles of glycans and lectins across vascular signaling, implying potential targets for diagnostic and therapeutic innovation.
Emerging findings suggest that glycans play central roles in vascular processes, including those involving endothelial cell signaling, angiogenesis, lymphangiogenesis, hemostasis, leukocyte trafficking and inflammation. This collection of specialized reviews seeks to illustrate specific examples of how glycans and their binding partners are integral to vascular biology with the ultimate goal of identifying open questions in this interdisciplinary field and to capitalize on this information for the design of novel diagnostic and therapeutic approaches. In the past few years, it has become more and more evident that glycans and glycan-binding proteins are integral to many processes linked to vascular biology, including the formation of new blood or lymphatic vessels by sprouting (angiogenesis or lymphangiogenesis), leukocyte trafficking and hemostasis (Varki et al. 2008). These processes can ultimately influence a broad range of pathologic conditions such as tumor growth and metastasis, cardiovascular diseases, reproductive disorders, ocular diseases, thrombosis and atherosclesosis. The activation of vascular signaling programs requires the involvement of cells of the vascular wall including endothelial cells and pericytes as well as cells that interact actively with the vascular wall such as leukocytes and platelets (Chung and Ferrara 2011). Glycans and glycan-binding proteins can control communication between these cell types by influencing cellular events, such as endocytosis, trafficking and signaling of canonical receptors, endothelial cell tip formation and branching, pericyte coverage, cytokine secretion, transendothelial leukocyte trafficking and platelet–endothelial cell interactions. Although the diversity of pathways that could be shaped by glycosylation is as broad as vascular biology itself, this special issue will illustrate only some examples of these regulated pathways and will touch on key topics under active investigation around the world. First, Herzog and colleagues discuss exciting findings on how O-glycosylation preserves vascular integrity and how it separates blood and lymphatic vessels in different tissues during development (Herzog et al. 2014). Then, Wright and Cooper provide a comprehensive overview on the mechanisms by which glycosylation influences different events involved in leukocyte trafficking through blood and lymphatic vessels. In particular, the authors emphasize the critical role of glycosyltransferases, selectins, sialomucins and galectins in regulating leukocyte capture and rolling, firm adhesion and extravasation and suggest that different glycans may serve as “navigation codes” during leukocyte trafficking (Wright and Cooper 2014). The essential role of glycans and glycan-binding proteins in vascular processes involving platelets is emphasized in the review by Etulian and Schattner who highlight the involvement of C-type lectins (e.g., P-selectin and CLEC-2), I-type lectins (e.g., PECAM-1), galectins (mainly galectin-1, -3 and -8) and glycosaminoglycan-binding proteins in platelet–endothelial cell interactions and discuss the possible implications of these interactions in hemostasis, thrombosis, atherosclerosis and cancer progression (Etulain and Schattner 2014). The impact of glycosylation in endothelial cell survival is highlighted in the review by Kitazume and colleagues who discuss the key roles of sialic acid in controlling PECAM-1 homotypic interactions and regulating endothelial cell signaling and viability (Kitazume et al. 2014). Next, Ustyuzhanina et al. describe the growing body of evidence highlighting the role of sulfated algae polysaccharides (fucoidans) in the control of angiogenesis and inflammation. Particularly, the authors discuss how the structure of fucoidans can govern their pro- or antiangiogenic activity (Ustyuzhanina et al. 2014). Because eye diseases, involving dysregulated angiogenesis are among the most common causes of blindness worldwide, Markowska and Panjwani discuss how glycans and glycan-binding proteins can modulate corneal, retinal and choroidal neovascularization. Particularly, the authors center their attention on the role of galectin-3 and its glycosylated cellular receptors in ocular angiogenesis (Markowska and Panjwani 2014). Finally, Croci et al. discuss the relevance of lectin–glycan networks in tumor vascularization, their regulation by hypoxia and the role of endothelial cell glycosylation in modulating sensitivity to antiangiogenic treatments (Croci et al. 2014). This collection of review articles are only examples of the emerging literature illustrating the relevance of the glycosylation machinery in vascular processes. We hope that these reviews will encourage the broad biomedical community to tackle on this exciting field and to address the myriad of unanswered questions at the frontiers of vascular biology and glycosciences.
No takes yet. Share an insight, caveat, or question.
Thijssen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: